Yet another patent granted for DAV132 in the USA

Yet another patent granted for DAV132 in the USA


Back to news page

Yet another patent granted for DAV132 in the USA

The US Patent and Trademark Office has recently granted a new patent for Da Volterra in the USA. The patent was issued under number 10,052,288 and relates to DAV132, our phase 2 asset to protect the intestinal microbiota from antibiotic-induced disruption.

This new patent reinforces our intellectual property portfolio and comes as a complement to the already 100+ patents protecting our products worldwide.